111 related articles for article (PubMed ID: 32187428)
1. New hepatitis C diagnoses in Ontario, Canada are associated with the local prescription patterns of a controlled-release opioid.
Meyer M; Bondy L; Koivu S; Koval J; Scarffe AD; Silverman MS
J Viral Hepat; 2020 Aug; 27(8):774-780. PubMed ID: 32187428
[TBL] [Abstract][Full Text] [Related]
2. Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment.
Ball LJ; Venner C; Tirona RG; Arts E; Gupta K; Wiener JC; Koivu S; Silverman MS
J Acquir Immune Defic Syndr; 2019 Aug; 81(4):e127-e134. PubMed ID: 31021987
[TBL] [Abstract][Full Text] [Related]
3. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
[TBL] [Abstract][Full Text] [Related]
4. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
[TBL] [Abstract][Full Text] [Related]
5. Controlled-release hydromorphone and risk of infection in adults: a systematic review.
Tricco AC; Parker A; Hezam A; Nincic V; Yazdi F; Lai Y; Harris C; Bouck Z; Bayoumi AM; Straus SE
Harm Reduct J; 2023 Apr; 20(1):60. PubMed ID: 37118805
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
[TBL] [Abstract][Full Text] [Related]
7. Hydromorphone and the risk of infective endocarditis among people who inject drugs: a population-based, retrospective cohort study.
Silverman M; Slater J; Jandoc R; Koivu S; Garg AX; Weir MA
Lancet Infect Dis; 2020 Apr; 20(4):487-497. PubMed ID: 31981474
[TBL] [Abstract][Full Text] [Related]
8. Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth.
Hadland SE; DeBeck K; Kerr T; Feng C; Montaner JS; Wood E
BMJ Open; 2014 Jul; 4(7):e005419. PubMed ID: 25052173
[TBL] [Abstract][Full Text] [Related]
9. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
Bruneau J; Roy E; Arruda N; Zang G; Jutras-Aswad D
Addiction; 2012 Jul; 107(7):1318-27. PubMed ID: 22248184
[TBL] [Abstract][Full Text] [Related]
10. Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion.
Wilton J; Wong S; Purssell R; Abdia Y; Chong M; Karim ME; MacInnes A; Bartlett SR; Balshaw RF; Gomes T; Yu A; Alvarez M; Dart RC; Krajden M; Buxton JA; Janjua NZ
JAMA Netw Open; 2022 Jan; 5(1):e2143050. PubMed ID: 35019983
[TBL] [Abstract][Full Text] [Related]
11. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J
J Viral Hepat; 2019 Dec; 26(12):1413-1422. PubMed ID: 31433888
[TBL] [Abstract][Full Text] [Related]
12. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
[TBL] [Abstract][Full Text] [Related]
13. Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016.
Fischer B; Jones W; Varatharajan T; Malta M; Kurdyak P
Prev Med; 2018 Nov; 116():112-118. PubMed ID: 30217407
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario.
Guan Q; Khuu W; Martins D; Tadrous M; Chiu M; Do MT; Gomes T
Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):256-262. PubMed ID: 29911823
[TBL] [Abstract][Full Text] [Related]
15. The role of living context in prescription opioid injection and the associated risk of hepatitis C infection.
Sacks-Davis R; Daniel M; Roy É; Kestens Y; Zang G; Ramos Y; Hellard M; Jutras Aswad D; Bruneau J
Addiction; 2016 Nov; 111(11):1985-1996. PubMed ID: 27238912
[TBL] [Abstract][Full Text] [Related]
16. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
17. Trends in Postpartum Opioid Prescribing: A Time Series Analysis.
Zipursky JS; Pang A; Paterson JM; Austin PC; Mamdani M; Gomes T; Ray JG; Juurlink DN
Clin Pharmacol Ther; 2021 Oct; 110(4):1004-1010. PubMed ID: 34032277
[TBL] [Abstract][Full Text] [Related]
18. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.
Palmateer N; Hutchinson S; McAllister G; Munro A; Cameron S; Goldberg D; Taylor A
J Viral Hepat; 2014 Jan; 21(1):25-32. PubMed ID: 24329854
[TBL] [Abstract][Full Text] [Related]
19. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
[TBL] [Abstract][Full Text] [Related]
20. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
Rosińska M; Sierosławski J; Wiessing L
BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
